X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11179) 11179
Newsletter (270) 270
Book Chapter (55) 55
Newspaper Article (39) 39
Dissertation (32) 32
Publication (11) 11
Conference Proceeding (7) 7
Magazine Article (7) 7
Reference (3) 3
Web Resource (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
temozolomide (9442) 9442
humans (6531) 6531
oncology (5257) 5257
glioblastoma (4747) 4747
female (3230) 3230
chemotherapy (3178) 3178
male (3178) 3178
radiotherapy (3156) 3156
cancer (3121) 3121
middle aged (2577) 2577
dacarbazine - analogs & derivatives (2568) 2568
glioblastoma multiforme (2404) 2404
adult (2326) 2326
clinical neurology (2324) 2324
aged (2201) 2201
survival (2201) 2201
glioma (2056) 2056
adjuvant temozolomide (2004) 2004
tumors (1997) 1997
brain neoplasms - drug therapy (1996) 1996
gliomas (1989) 1989
brain neoplasms - pathology (1727) 1727
cell line, tumor (1533) 1533
animals (1510) 1510
prognosis (1489) 1489
glioblastoma - drug therapy (1469) 1469
brain tumors (1399) 1399
care and treatment (1380) 1380
apoptosis (1377) 1377
glioblastoma - pathology (1338) 1338
surgery (1310) 1310
treatment outcome (1285) 1285
dacarbazine - therapeutic use (1258) 1258
brain cancer (1256) 1256
malignant glioma (1251) 1251
medicine & public health (1227) 1227
research (1186) 1186
expression (1162) 1162
analysis (1118) 1118
antineoplastic agents, alkylating - therapeutic use (1074) 1074
brain neoplasms - therapy (1069) 1069
brain neoplasms - genetics (982) 982
brain neoplasms - mortality (966) 966
neurology (953) 953
mice (934) 934
radiation therapy (910) 910
therapy (903) 903
retrospective studies (897) 897
glioma - drug therapy (872) 872
radiation (868) 868
concomitant (865) 865
bevacizumab (858) 858
radiation-therapy (849) 849
brain (816) 816
glioblastoma - genetics (807) 807
glioma - pathology (800) 800
medical prognosis (795) 795
combined modality therapy (788) 788
patients (781) 781
glioblastoma - therapy (780) 780
dacarbazine - administration & dosage (778) 778
multiforme (777) 777
health aspects (767) 767
young adult (762) 762
glioblastoma - mortality (754) 754
phase-ii (754) 754
dacarbazine - pharmacology (745) 745
newly-diagnosed glioblastoma (730) 730
neurosciences (726) 726
cell biology (724) 724
aged, 80 and over (722) 722
pharmacology & pharmacy (722) 722
phase-ii trial (720) 720
mgmt (719) 719
brain neoplasms - metabolism (705) 705
trial (704) 704
magnetic resonance imaging (702) 702
brain neoplasms - radiotherapy (692) 692
dna methylation (672) 672
cancer therapies (668) 668
survival analysis (662) 662
antineoplastic agents - therapeutic use (658) 658
disease-free survival (652) 652
glioblastoma - metabolism (645) 645
antineoplastic combined chemotherapy protocols - therapeutic use (642) 642
gene expression (633) 633
glioblastoma-multiforme (631) 631
adolescent (621) 621
methylation (613) 613
clinical trials (598) 598
proteins (591) 591
malignant gliomas (590) 590
radiology, nuclear medicine & medical imaging (588) 588
survival rate (570) 570
antineoplastic agents (566) 566
drug therapy (566) 566
development and progression (554) 554
cells (539) 539
antimitotic agents (535) 535
glioblastoma - radiotherapy (535) 535
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11301) 11301
French (107) 107
German (74) 74
Japanese (51) 51
Spanish (32) 32
Chinese (18) 18
Czech (15) 15
Polish (12) 12
Portuguese (12) 12
Korean (10) 10
Turkish (7) 7
Hungarian (6) 6
Italian (4) 4
Russian (4) 4
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuro-oncology (Charlottesville, Va.), ISSN 1523-5866, 2013, Volume 15, Issue 1, pp. 4 - 27
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 06/2018, Volume 103, Issue 8, p. 3115
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 916 - 926
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, pp. e0199076 - e0199076
We determine an optimal protocol for temozolomide using population variability and dynamic optimization techniques inspired by artificial intelligence. We use... 
BREAST-CANCER | TRIAL | PHARMACOKINETICS | ONCOLOGY | MULTIDISCIPLINARY SCIENCES | PRECISION MEDICINE | MODEL | METRONOMIC CHEMOTHERAPY | CHILDREN | Temozolomide - pharmacokinetics | Artificial Intelligence | Humans | Antineoplastic Agents, Alkylating - pharmacology | Treatment Outcome | Antineoplastic Agents, Alkylating - pharmacokinetics | Antineoplastic Agents, Alkylating - administration & dosage | Temozolomide - pharmacology | Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Dose-Response Relationship, Drug | Temozolomide - therapeutic use | Algorithms | Models, Biological | Temozolomide - administration & dosage | Neoplasms - pathology | Monte Carlo Method | Technology application | Usage | Temozolomide | Pharmacokinetics | Artificial intelligence | Testing | Physiological effects | Operations research | Toxicity | Brain cancer | Variability | Clinical trials | Oncology | Metastasis | Cancer therapies | Optimization | Confidence intervals | Population | Myelosuppression | Drug dosages | Monte Carlo method | Pharmacodynamics | Computer simulation | Search algorithms | Neutrophils | Periodicity | Pharmacology | Breast cancer | Periodic variations | Patients | Chemotherapy | Neural networks | Tumors | Index Medicus | Business administration | Economics and Finance | Humanities and Social Sciences | FDA approval
Journal Article
Clinical cancer research, ISSN 1557-3265, 2017, Volume 23, Issue 8, pp. 1898 - 1909
Purpose: Patients with glioblastoma have less than 15-month median survival despite surgical resection, high-dose radiation, and chemotherapy with... 
REGRESSION | TRIAL | ONCOLOGY | HOMEOSTATIC EXPANSION | DENDRITIC CELL VACCINES | PROLIFERATION | MICE | COMPARTMENT | T-CELLS | ADJUVANT TEMOZOLOMIDE | Phosphoproteins - immunology | Viral Matrix Proteins - therapeutic use | Dendritic Cells - immunology | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | T-Lymphocytes, Regulatory - immunology | Cancer Vaccines - therapeutic use | Brain Neoplasms - immunology | Dacarbazine - analogs & derivatives | Female | Phosphoproteins - therapeutic use | Brain Neoplasms - mortality | Dacarbazine - administration & dosage | Adjuvants, Immunologic | Kaplan-Meier Estimate | Combined Modality Therapy | Glioblastoma - therapy | Disease-Free Survival | Glioblastoma - immunology | Brain Neoplasms - therapy | Aged | Viral Matrix Proteins - immunology | Dendritic Cells - transplantation | Glioblastoma - mortality | Granulocyte-Macrophage Colony-Stimulating Factor | Cell proliferation | Vaccination | Glioblastoma | Radiation | Lymphocytes T | mRNA | Vaccines | Macrophages | Confidence intervals | Lymphocytes | Surgery | Design standards | DNA methylation | Colony-stimulating factor | Cytomegalovirus | Cell survival | Immune response | Dendritic cells | Immunoregulation | Granulocyte-macrophage colony-stimulating factor | Glycoproteins | Survival | Patients | Radiation dosage | Chemotherapy | Experimental design | Medical prognosis | Pp65 protein | Temozolomide | Methylation | Cancer | dose-intensified temozolomide | glioblastoma | pp65 | cytomegalovirus
Journal Article
Annals of oncology, ISSN 0923-7534, 2018, Volume 29, Issue 1, pp. 154 - 161
Journal Article
Neuro-oncology (Charlottesville, Va.), ISSN 1523-5866, 2018, Volume 20, Issue 12, pp. 1566 - 1572
Abstract Temozolomide is the most widely used chemotherapy for patients with glioblastoma (GBM) despite the fact that approximately half of treated patients... 
temozolomide | immunomodulation | glioblastoma | immunity | chemotherapy | PLUS TEMOZOLOMIDE | NEWLY-DIAGNOSED GLIOBLASTOMA | HUMAN MONOCYTES | CLINICAL NEUROLOGY | ADJUVANT TEMOZOLOMIDE | RADIATION-THERAPY | TUMOR-INFILTRATING LYMPHOCYTES | PHASE-II TRIAL | ONCOLOGY | REGULATORY T-CELLS | SUPPRESSOR-CELLS | Review
Journal Article
Journal of neuro-oncology, ISSN 1573-7373, 2018, Volume 138, Issue 3, pp. 627 - 636
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 6, pp. e0217881 - e0217881
Journal Article